We are live on
!
Find out more
LP
LGL Partners Portfolio holdings
AUM
$273M
1-Year Est. Return
24.15%
This Fund
S&P 500
This Quarter
Est. Return
+14.57%
1 Year Est. Return
+24.15%
3 Year Est. Return
+68.92%
5 Year Est. Return
+65.82%
10 Year Est. Return
+206.18%
AUM
$273M
AUM Growth
+$30.5M
(+13%)
Cap. Flow
-$2.74M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
80.4%
Holding
73
New
7
Increased
40
Reduced
6
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$550K |
| 2 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$502K |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$461K |
| 4 |
iShares Expanded Tech-Software Sector ETF
IGV
|
+$418K |
| 5 |
HDV
iShares Core High Dividend ETF
HDV
|
+$358K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.19M |
| 2 |
Liquidia Corp
LQDA
|
+$1.09M |
| 3 |
Coupang
CPNG
|
+$850K |
| 4 |
Sabra Healthcare REIT
SBRA
|
+$794K |
| 5 |
JPMorgan Chase
JPM
|
+$615K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 0.82% |
| 2 | Technology | 0.82% |
| 3 | Healthcare | 0.45% |
| 4 | Industrials | 0.36% |
| 5 | Communication Services | 0.09% |
No holdings matched the selected filter criteria.
Similar funds
SN
MC
SCM
OL
JWM
MP
AGP
3C
LGL Partners's Q2 2026 Portfolio in Review
As of Q2 2026, LGL Partners held 73 positions worth $273M, up 13% from $243M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
LGL Partners's Q2 2026 filing shows 7 new, 40 increased, 6 reduced and 11 closed positions. Its largest new stake was Vanguard S&P 500 ETF: 825 shares worth $567K. The largest sale was Eli Lilly, an estimated $1.19M.
By sector, the portfolio is most concentrated in Financials at 0.82% of assets, down from 1.1% a quarter earlier, followed by Technology and Healthcare.
- LGL Partners's largest Q2 2026 buy was Vanguard S&P 500 ETF: 825 shares worth $567K.
- LGL Partners added most to iShares Expanded Tech-Software Sector ETF in Q2 2026, an estimated $418K increase.
- LGL Partners's biggest Q2 2026 reduction was Sabra Healthcare REIT, cutting an estimated $794K.
- LGL Partners fully exited Eli Lilly in Q2 2026, selling an estimated $1.19M.
- LGL Partners's ten largest holdings make up 80% of its $273M portfolio in Q2 2026.
- LGL Partners opened 7 new positions and closed 11 in Q2 2026.
- LGL Partners's portfolio value rose 13% quarter-over-quarter to $273M.
Based on LGL Partners's 13F filing for Q2 2026, filed 27 Jul 2026.